OMAHA - In addition to serving as one of the lead quarantine sites for Americans diagnosed with COVID-19, the University of Nebraska Medical Center is spearheading the effort to find a treatment for the respiratory disease caused by the coronavirus.

Tuesday, UNMC announced the first clinical trial in the U.S. of remdesivir, a "broad-spectrum" antiviral therapy that has proved effective against SARS and MERS — other respiratory diseases caused by varying strains of the virus — as well as against the Ebola virus.

View the article HERE